Table1. Summary of the spatio-temporally specific contribution of the Wnt11-CreER expressing cells to the embryonic heart.
Tamoxifen administration (Embryonic Day-E) | Dissection (Embryonic Day –E) | Myocardium | Endocardium | Epicardium | ||||||
---|---|---|---|---|---|---|---|---|---|---|
LV | RV | OFT | A | LV | RV | OFT | A | |||
6.5 | 8.5 | - | - | - | - | ++ | ++ | ++ | ++ | - |
7.0 | 9.0 | ++ | - | - | - | +++ | +++ | +++ | ++ | - |
7.5 | 9.5/10.5 | +++ | - | - | - | +++ | +++ | +++ | ++ | - |
8.0 | 9.5 | ++ | ++ | +/- | - | +++ | +++ | +++ | ++ | - |
8.5 | 12.5/16.5 | + | +++ | ++ | - | +++ | +++ | +++ | ++ | + |
9.0 | 10.5/12.5 | +/- | ++ | +++ | - | +++ | +++ | +++ | ++ | ++ |
9.5 | 12.5 | - | + | ++ | - | +++ | +++ | +++ | ++ | +++ |
10.5 | 12.5 | - | - | + | - | +++ | +++ | +++ | ++ | +++ |
The (+) and (-) indicate the presence and absence of tdTomato expressing cell in each compartment, respectively, with (+++) indicating highest levels of tdTomato expressing cells present.